Idiopathic Primary Osteo-myelofibrosis: A Clinico-Pathological Study on 208 Patients with Special Emphasis on Evolution of Disease Features, Differentiation from Essential Thrombocythemia and Variables of Prognostic Impact

References

• Varki A., Lottenberg R., Griffith R., Reinhard E. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognosis variables predicting survival. Medicine 1983; 62: 353–371
   PubMed Web of Science ®Google Scholar
• Geary C.G. Clinical and hematological aspects of chronic myelofibrosis. Myelofibrosis, pathophysiology and clinical management, S.M. Lewis. Marcel Dekker, New York 1985; 15–49
   Google Scholar
• Lewis S.M. Myelofibrosis: historical perspective. Myelofibrosis, pathophysiology and clinical management, S.M. Lewis. Marcel Dekker, New York 1985; 1–13
   Google Scholar
• Anger B., Seidler R., Haug U., Popp C., Heimpel H. Idiopathic myelofibrosis: Retrospective study of 103 patients. Haematologica 1990; 75: 228–234
   PubMedGoogle Scholar
• Visani G., Finelli C., Castelli U., Petti M.C., Ricci P., Vianelli N., Gianni L., Zuffa E., Aloe Spiriti M.A., Latagliata R., Pileri S., Magrini U., Gugliotta L., Morra E., Bernasconi C., Mandelli F., Tura S. Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients. Br. J. Haematol 1990; 75: 4–9
   PubMed Web of Science ®Google Scholar
• Rupoli S., Da Lio L., Sisti S., Campanati G., Salvi A., Brianzoni M.R., D'Amico S., Cinciripini A., Leoni P. Primary myelofibrosis: A detailed statistical analysis of the clinicopatho-logical variables influencing survival. Ann. Hematol 1994; 68: 205–212
   PubMed Web of Science ®Google Scholar
• Ward H.P., Block M.H. The natural history of agno-genic myeloid metaplasia. Medicine 1971; 50: 357–420
   PubMed Web of Science ®Google Scholar
• Wolf B.C., Neiman R.S. Myelofibrosis with myeloid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 1985; 65: 803–809
   PubMed Web of Science ®Google Scholar
• Barosi G., Berzuini C., Liberator L.N., Costa A., Polino G., Ascari E. A prognostic classification of myelofibrosis with myeloid metaplasia. Br. J. Haematol 1988; 70: 397–401
   PubMed Web of Science ®Google Scholar
• Pitcock J.A., Reinhard E.H., Justus B.W., Mendelsohn R.S. A clinical and pathological study of seventy cases of myelofibrosis. Ann. Int. Med. 1962; 57: 73–84
   PubMed Web of Science ®Google Scholar
• Manoharan A., Smart R.C., Pitney W.R. Chemotherapy resolves symptoms and reverses fibrosis in myelofibrosis. Scand. J. Haematol 1982; 33: 453–459
   Google Scholar
• Lofvenberg E., Wahlin A., Roos G., Ost A. Reversal of myelofibrosis by hydroxyurea. Eur. J. Haematol 1990; 44: 33–38
   PubMed Web of Science ®Google Scholar
• Hasselbalch H., Jensen B.A. Prognostic factors in idiopathic myelofibrosis: A simple scoring system with prognostic significance. Eur. J. Haematol 1990; 44: 172–178
   PubMed Web of Science ®Google Scholar
• Hasselbalch H., Lisse I. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis. Eur. J. Haematol 1991; 46: 285–289
   PubMed Web of Science ®Google Scholar
• Thiele J., Zankovich R., Steinberg T., Fischer R., Diehl V. Agnogenic myeloid metaplasia (AMM)—correlation of bone marrow lesions with laboratory data: A longitudinal clinico-pathological study on 114 patients. Hematol. Oncol 1989; 7: 327–343
   PubMed Web of Science ®Google Scholar
• Pereira A., Cervantes F., Brugues R., Rozman C. Bone marrow histopathology in primary myelofibrosis: Clinical and haematologic correlations and prognostic evaluation. Eur. J. Haematol 1990; 44: 94–98
   Web of Science ®Google Scholar
• Njoku O.S., Lewis S.M., Catovsky D., Gordon-Smith E.C. Anaemia in myelofibrosis: Its value in prognosis. Br. J. Haematol 1983; 54: 79–89
   PubMed Web of Science ®Google Scholar
• Burkhardt R., Bartl R., Jager K., Frisch B., Kettner B., Mahl G., Sund M. Chronic myeloproliferative disorders (CMPD). Path. Res. Pract. 1984; 179: 131–186
   PubMed Web of Science ®Google Scholar
• Thiele J., Hoppner B., Zankovich R., Fischer R. Histomorphometry of bone marrow biopsies in primary os-teomyelofibrosis/-sclerosis (agnogenic myeoloid metaplasia)—correlations between laboratory and morphological features. Virchows Arch. A. Pathol Anat. 1989; 415: 191–202
   Google Scholar
• Georgii A., Vykoupil K.F., Buhr T., Choritz H., Dohler U., Kaloutsi V., Werner M. Chronic myeloproliferative disorders in bone marrow biopsies. Pathol. Res. Pract. 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Buhr T., Georgii A., Schuppan O., Amor A., Kaloutsi V. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann. Hematol 1992; 64: 286–291
   PubMed Web of Science ®Google Scholar
• Buhr T., Georgii A., Choritz H. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Path. Res. Pract. 1993; 189: 121–132
   PubMed Web of Science ®Google Scholar
• Bartl R., Frisch B., Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (CMPD). Eur. J. Haematol 1993; 50: 41–52
   PubMed Web of Science ®Google Scholar
• Buss D.H., O'Connor M.L., Woodruff R.D., Richards F., II, Brockschmidt J.K. Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. Arch. Pathol. Lab. Med. 1991; 115: 475–480
   PubMed Web of Science ®Google Scholar
• Chelloul N., Jacquillat P., Briere J., Laval-Jeantet J.P., Vorhauer-Atlan W. Valeur prognostique des lesions osteomedullaires de splenomegalie myeloide primitive. Nouv. Press. Med. 1975; 43: 3060–3062
   Google Scholar
• Manoharan A., Smart R.C., Pitney W.R. Prognostic factors in myelofibrosis. Pathology 1982; 14: 455–61
   PubMed Web of Science ®Google Scholar
• Rozman C., Giralt M., Feliu R., Rubio D., Cortes M.T. Life expectancy of patients with chronic nonleukemic myeloprolif-erative disorders. Cancer 1991; 67: 2658–2663
   PubMed Web of Science ®Google Scholar
• Thiele J., Windecker R., Kvasnicka H.M., Titius B.R., Zankovich R., Fischer R. Erythropoiesis in primary (id-iopathic) osteomyelofibrosis: Quantification, PCNA-reactivity, and prognostic impact. Am. J. Hematol. 1994; 46: 36–42
   PubMed Web of Science ®Google Scholar
• Gustavsson P., Holm J., Wahlin A., Norberg B. Staging of idiopathic myelofibrosis. Significance of haemoglobin value and reticulocyte count. Ada. Med. Stand. 1985; 218: 487–91
   PubMed Web of Science ®Google Scholar
• Lohmann T.P., Beckman E.N. Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch. Pathol. Lab. Med. 1983; 107: 593–594
   PubMed Web of Science ®Google Scholar
• Schaefer H.E. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. Pathology of the bone marrow, K. Lennert, K. Huebner. G. Fischer, New York, Stuttgart 1984; 6–9
   Google Scholar
• Thiele J., Zankovich R., Schneider G., Kremer B., Fischer R., Diehl V. Primary (essential) thrombocythemia versus poly-cythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies. Analyt. Quant. Cytol. Histol 1988; 10: 375–382
   PubMed Web of Science ®Google Scholar
• Fisher R.A. Statistical methods for research workers. Oliver and Boyd, Edinburgh 1972
   Google Scholar
• Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer. 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 32: 933–942
   Web of Science ®Google Scholar
• Hakama M., Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J. Chron. Dis. 1977; 30: 585–597
   PubMedGoogle Scholar
• Hand H.J., Laszlo J., Case D.C., Murphy S., Reichert T.A., Tso C.Y., Wasserman L.R. Differentiation between essential thrombocythemia and polycythemia vera with marked throm-bocytosis. Am. J. Hematol. 1987; 25: 191–201
   PubMed Web of Science ®Google Scholar
• Murphy S., Hand H., Rosenthal D., Laszlo J. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin. Hematol. 1986; 23: 177–182
   PubMed Web of Science ®Google Scholar
• Cervantes F., Tassies D., Salgado C., Rovira M., Pereira A., Rozman C. Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients. Acta. Haematol. 1991; 85: 124–127
   PubMed Web of Science ®Google Scholar
• Hasselbalch H. Idiopathic myelofibrosis: A clinical study of 80 patients. Am. J. Hematol. 1990; 34: 291–300
   PubMed Web of Science ®Google Scholar
• Dickstein J.I., Vardiman J.W. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol. 1993; 99: 513–525
   PubMed Web of Science ®Google Scholar
• Howarth J.E., Waters H.M., Hyde K., Geary C.G. Detection of erythroid hypoplasia in myelofibrosis using erythroki-netic studies. J. Clin. Pathol. 1989; 24: 1250–1252
   Web of Science ®Google Scholar
• Hoffbrand A.V., Chanarin I., Kremenchuzky S., Szur L., Water A.H., Mollin D.L. Megaloblastic anaemia in myeloscle-rosis. Q. J. Med 1968; 37: 493–516
   Google Scholar
• Wolf B.C., Neiman R.S. Hypothesis: Splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnognic myeloid metaplasia. Hematol. Pathol. 1987; 1: 77–80
   PubMedGoogle Scholar
• Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M. Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447
   PubMed Web of Science ®Google Scholar
• Hehlmann R., Jahn M., Baumann B., Kopcke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988; 61: 2487–2496
   PubMed Web of Science ®Google Scholar
• Lahuerta-Palacios J.J., Bornstein R., Fernandez-Debora F., Gutierrez-Rivas E., Ortiz M.C., Larregla S., Calandre L., Montero-Castillo J. Controlled and uncontrolled thrombo-cytosis. Its clinical role in essential thrombocythemia. Cancer 1988; 61: 1207–1212
   PubMed Web of Science ®Google Scholar
• Dudley J.M., Messinezy M., Eridani S., Holland L.J., Lawrie A., Nunan T.O., Sawyer B., Savidge G.F., Pearson T.C. Primary thrombocythaemia: Diagnostic criteria and a simple scoring system for positive diagnosis. Br. J. Hematol. 1989; 71: 331–335
   PubMed Web of Science ®Google Scholar
• Mitus A.J., Schafer A.I. Thrombocytosis and thrombocythemia. Hematol./Oncol. Clin. N. Am. 1990; 4: 157–178
   PubMed Web of Science ®Google Scholar
• Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghiero F., Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J. Clin. Oncol. 1990; 8: 556–562
   PubMed Web of Science ®Google Scholar
• Fenaux P., Simon M., Caulier M.T., Lai I.L., Goudemmand J., Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990; 66: 549–556
   PubMed Web of Science ®Google Scholar
• Colombi M., Radaelli F., Zocchi L., Maiolo A.T. Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients. Cancer 1991; 67: 2926–2930
   PubMed Web of Science ®Google Scholar